In the early days and months of the COVID-19 pandemic, the VA and other healthcare systems were focused on the daunting work of helping patients survive the acute effects of the disease.
With the PACT Act set to officially go into effect this month, legislators are watching VA closely to see how the department deals with the hundreds of thousands of expected new claims.
While the pandemic has resulted in an explosion in the use of telehealth among federal health agencies, it also has created opportunities for fraud and waste, according to a recent joint report from six Offices of the Inspector General (OIGs).
Before year’s end, Congress passed the $858 billion National Defense Authorization Act (NDAA) for FY 2023, the largest defense spending bill of its kind.
How does Health-Related Quality of Life (HRQoL) after treatment of prostate cancer (PCa) differ for patients of different races?
While it is well understood that prostate cancer (PCa) and its treatment can have significant and pervasive sexual side effects for the male patients, less attention has been paid to their partners.
Can genetic scores provide an objective measure of prostate cancer risk and aid screening decisions?
As part of the continual evolution of pneumococcal vaccination recommendations, guidelines recently have been updated to urge more use of pneumococcal conjugate vaccines in older adults.
Even after years of the COVID-19 pandemic, data remains somewhat limited on the safety profile of SARS-CoV-2 vaccine in patients taking immunosuppressive medications.
While co-infection with more than one respiratory virus was especially a problem this fall and winter, it has happened before, especially in an environment where SARS-CoV-2 is circulating.
While it is widely known that African Americans (AA) are at higher risk for multiple myeloma (MM), precisely what factors create the disparity are not well understood.
Walter Reed, NIAID Scientists Help Develop Monoclonal Antibodies That Might Block Epstein-Barr Virus Infection; EBV Linked to MS Development
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and Walter Reed Army Institute of Research (WRAIR) have developed a panel of investigational monoclonal antibodies (mAbs) that target two key proteins—gH and gL—on the surface of the Epstein-Barr virus (EBV).
Most new diagnoses of oropharyngeal cancer, a type of head and neck cancer, are driven by human papillomavirus (HPV) infections, with distinct genetic and immune differences in HPV-driven and non-HPV-driven head and neck cancer, according to a new study.
Despite misconceptions that prior COVID-19 infections can keep patients from having severe cases in the future, a new study suggests that recurrent cases pile on the risk of adverse health conditions in multiple organ systems.
Much of the focus during the COVID-19 pandemic has been on the infection itself, as well as persistent symptoms. But many other aspects of healthcare underwent changes of SARS-CoV-2 and the efforts to combat it.
Similar Cardiovascular Outcomes Found in Veterans Treated With Two Common Blood Pressure Medications — Chlorthalidone and Hydrochlorothiazide
In “surprising” results, two common diuretics used to control blood pressure, chlorthalidone and hydrochlorothiazide, had no differences in outcomes for cardiovascular events, including death, in veteran patients, according to a new study.
As we enter a new year, like many Americans, I am hopeful that the world’s challenges of the last few years will ease. I am somewhat confident that 2023 will bring improvement to the general human condition, since the first three years of this decade represent such a low bar upon which to improve. It is indeed hard to be optimistic in the face of growing consequences of global warming, threats to our constitutional democracy, Russia’s war of aggression, disruptions in world supply chains, ongoing COVID-19 pandemic concerns and world economic instability, among many other adverse events. We must remain hopeful.
A federal judge called a man “a menace to society” —the first time he said he has done that —while sentencing him to 18 years in federal prison for stalking four female physicians who worked for the VA.
VA is slowly catching up on the appointments that were canceled in 2020 and 2021 due to the COVID-19 pandemic shutting down many nonessential services at VA hospitals.
Although vaccination and boosting remain the best defense against COVID-19, breakthrough infections among those vaccinated and boosted are exceedingly common.
Large VA Study Finds Lower Prostate Cancer Screening Rates Associated With Subsequent Increases in Metastatic Cancer
Aside from skin cancer, prostate cancer is the most common cancer among male veterans. When diagnosed at an early stage, prostate cancer is highly curable.
The removal of about 15,000 independent pharmacies from the TRICARE network has created an uproar.
VHA facilities appear to have limited staff who can provide mental health care services, and increasing mental health staffing could reduce suicide-related events in veterans, according to a new study.
The good news, according to a recent study, is that medical intensive care unit (MICU) admissions have been declining in people with HIV infection (PWH).
Human immunodeficiency virus (HIV) infection is known to be associated with subclinical cardiomyopathy, diastolic dysfunction and increased risk of cardiovascular death.
Even though about 20.9% of U.S. servicemembers report a high risk of HIV infection, only about 2,000 of them had accessed HIV pre-exposure prophylaxis (PrEP), as of 2017.
Sickle cell trait (SCT), a condition in which a person has one abnormal allele of the hemoglobin beta gene, affects an estimated 5.02% of non-Hispanic blacks, 1.08% of Hispanics and 0.1% of whites in the U.S. military.
In less than two decades, the advent of targeted therapies transformed chronic myeloid leukemia (CML) from a death sentence with a five-year survival rate of just 22% to a chronic condition with five-year survival exceeding 90%.
Veteran patients who received a COVID-19 vaccination series, plus a booster vaccine dose, had a low incidence of hospitalization, death or severe illness from COVID-19, according to a new study.
When antiviral agents and monoclonal antibodies were first authorized for use at the beginning of the year, few of them were prescribed at the VA, according to a new study.